Methotrexate

Generic Name
Methotrexate
Brand Names
Metoject, Nordimet, Otrexup, Rasuvo, Reditrex, Trexall, Xatmep, Jylamvo
Drug Type
Small Molecule
Chemical Formula
C20H22N8O5
CAS Number
59-05-2
Unique Ingredient Identifier
YL5FZ2Y5U1
Background

Methotrexate is a folate derivative that inhibits several enzymes responsible for nucleotide synthesis. This inhibition leads to suppression of inflammation as well as prevention of cell division. Because of these effects, methotrexate is often used to treat inflammation caused by arthritis or to control cell division in neoplastic diseases such as breast ca...

Indication

Methotrexate oral solution is indicated for pediatric acute lymphoblastic leukemia and pediatric polyarticular juvenile idiopathic arthritis. Methotrexate injections for subcutaneous use are indicated for severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and severe, recalcitrant, disabling psoriasis.
...

Associated Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Promyelocytic Leukemia, Bladder Cancer, Breast Cancer, Central Nervous System Lymphoma, Crohn's Disease (CD), Dermatomyositis (DM), Extrauterine Pregnancy, Gestational Trophoblastic Neoplasia, Graft-versus-host Disease (GVHD), Meningeal leukemia, Multiple Sclerosis, Mycosis Fungoides (MF), Non-Hodgkin's Lymphoma (NHL), Non-Hodgkin's Lymphoma, Relapsed, Osteosarcoma, Polyarticular Juvenile Idiopathic Arthritis, Polymyositis, Rheumatoid Arthritis, Soft Tissue Sarcoma, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Systemic Lupus Erythematosus, Uveitis, Nonleukemic meningeal cancer, Refractory Non-Hodgkin's lymphoma, Refractory Takayasu arteritis, Severe Psoriasis
Associated Therapies
Medically induced abortion
Clinical Trials
Related News

Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections

First Posted Date
2022-06-23
Last Posted Date
2022-09-21
Lead Sponsor
Cairo University
Target Recruit Count
18
Registration Number
NCT05429450
Locations
🇪🇬

Cairo University, Cairo, Egypt

Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis

First Posted Date
2022-06-22
Last Posted Date
2022-06-22
Lead Sponsor
Aswan University Hospital
Target Recruit Count
30
Registration Number
NCT05427175
Locations
🇪🇬

Aswan University - Faculty of Medicine, Aswan, Aswan Governorate, Egypt, Egypt

Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL

First Posted Date
2022-05-25
Last Posted Date
2022-05-25
Lead Sponsor
Peking Union Medical College Hospital
Target Recruit Count
50
Registration Number
NCT05390749
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

🇨🇳

Sanbo Brain Hospital Capital Medical University, Beijing, Beijing, China

🇨🇳

Beijing TianTan Hospital, Beijing, Beijing, China

Methotrexate in Patients With Early Rheumatoid Arthritis

Phase 4
Recruiting
Conditions
Rheumatoid Arthritis
Interventions
Drug: Methotrexate
First Posted Date
2022-04-29
Last Posted Date
2024-11-19
Lead Sponsor
Region Västerbotten
Target Recruit Count
212
Registration Number
NCT05353829
Locations
🇸🇪

Region Dalarna, Falun, Sweden

🇸🇪

Region Gävleborg, Gävle, Sweden

🇸🇪

Region Norrbotten, Luleå, Sweden

and more 10 locations

A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat

First Posted Date
2022-04-11
Last Posted Date
2023-09-01
Lead Sponsor
Children's Oncology Group
Registration Number
NCT05320380

Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers

Phase 2
Completed
Conditions
Non-melanoma Skin Cancers
Interventions
Drug: Methotrexate
First Posted Date
2022-04-07
Last Posted Date
2022-04-07
Lead Sponsor
Zagazig University
Target Recruit Count
60
Registration Number
NCT05315128
Locations
🇪🇬

Zagazig university, Zagazig, Sharkia, Egypt

MTX Hold During Covid-19 Booster

Phase 3
Conditions
Rheumatoid Arthritis
Interventions
Drug: MTX
First Posted Date
2022-04-06
Last Posted Date
2022-04-06
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
40
Registration Number
NCT05313061
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma

First Posted Date
2022-03-31
Last Posted Date
2024-08-02
Lead Sponsor
Alliance for Clinical Trials in Oncology
Target Recruit Count
66
Registration Number
NCT05303792
Locations
🇺🇸

NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States

🇺🇸

Marshfield Medical Center - Weston, Weston, Wisconsin, United States

🇺🇸

Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

and more 61 locations

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

First Posted Date
2022-03-31
Last Posted Date
2022-07-01
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
64
Registration Number
NCT05303727
Locations
🇨🇳

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Venetoclax Basket Trial for High Risk Hematologic Malignancies

First Posted Date
2022-03-23
Last Posted Date
2024-04-02
Lead Sponsor
Andrew E. Place, MD
Target Recruit Count
92
Registration Number
NCT05292664
Locations
🇺🇸

University of California San Francisco-Benioff Children's Hospital, San Francisco, California, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy